akerman.com
Akerman LLP
Three Brickell City Centre
98 Southeast Seventh Street
Suite 1100
Miami, FL 33131
T: 305 374 5600
F: 305 374 5095
August 7, 2026
Red Violet, Inc.
2650 North Military Trail
Suite 300
Boca Raton, Florida 33431
Re: Prospectus Supplement to Registration Statement on Form S-3
Ladies and Gentlemen:
We have acted as counsel to Red Violet, Inc., a Delaware corporation (the “Company”), in connection with the preparation and filing with the Securities and Exchange Commission (the “Commission”) of a Prospectus Supplement dated August 5, 2026 filed with the Commission pursuant to Rule 424(b) of the Securities Act of 1933, as amended (the “Securities Act”) on August 6, 2026 (the “Prospectus Supplement”), which supplements the Company’s Registration Statement on Form S-3 (File No. 333- 291649) which was declared effective on November 25, 2025, as amended from time to time (such Registration Statement in the form in which it became effective is referred to herein as the “Registration Statement”), under the Securities Act, including the base prospectus dated November 25, 2025 (together with the Prospectus Supplement, the “Prospectus”), relating to the registration and offering by the Company of 1,666,667 shares (the “Firm Shares”), and up to 250,000 additional shares (the “Additional Shares,” and together with the Firm Shares, collectively, the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”), pursuant to that certain Underwriting Agreement (the “Agreement”), dated August 5, 2026, among the Company, on the one hand, and Raymond James & Associates, Inc. and Needham & Company, LLC, as representatives of the several underwriters named in Schedule I to the Agreement, on the other hand.
This opinion letter is being furnished in accordance with the requirements of Item 601(b)(5) of Regulation S-K under the Securities Act.
In connection with this opinion, and as a basis for the opinion hereinafter set forth, we have examined (i) the Registration Statement, including the prospectus contained therein; (ii) the Prospectus Supplement; (iii) the executed Agreement; (iv) the Amended and Restated Certificate of Incorporation of the Company; (v) the Amended and Restated Bylaws of the Company; and (vi) certain resolutions and minutes of a meeting of the Board of Directors of the Company and resolutions and minutes of a meeting of the Pricing Committee of the Board of Directors of the Company relating to the issuance and sale of the Shares. We have also examined such corporate records, documents, instruments and certificates of public officials and of the Company that we have deemed necessary for the purpose of rendering the opinion set forth herein. We have also reviewed such matters of law as we have considered necessary or appropriate as a basis for the opinion set forth below.
With your permission, we have made and relied upon the following assumptions, without any investigation or inquiry by us, and our opinion expressed below is subject to, and limited and qualified by the effect of, all such assumptions: (i) all corporate records furnished to us by the Company are accurate and complete; (ii) the Registration Statement, the Agreement and the Prospectus Supplement filed by the Company with the Commission are identical to the forms of documents that we have reviewed; (iii) all statements as to factual matters that are contained in the